Watchlist Price Alert

Outlook Therapeutics Inc. (OTLK)

NASDAQ: OTLK · Real-Time Price · USD

1.71

-0.06 (-3.39%)

At close: Jun 17, 2025, 2:22 PM

Outlook Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cash & Equivalents	14.93M	23.39M	17.4M	14.48M	12.54M	8.02M	1.72M	3.19M	2.35M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	693.19K	793.93K	804.93K	853.66K	900K	n/a	n/a	n/a	216.09K
Other Long-Term Assets	439.28K	501.3K	132.01K	174.59K	394.45K	457.48K	491.04K	740.36K	852.8K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	12.49M	7.59M	n/a	n/a	n/a	1.7M	n/a	n/a	n/a
Total Current Assets	27.42M	30.98M	27.52M	21.51M	17.94M	13.5M	3.3M	3.9M	5.68M
Property-Plant & Equipment	274.64K	26.17K	70.36K	275.05K	494.24K	3.18M	18.49M	16.09M	16.96M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.41M	1.32M	1.01M	1.3M	1.79M	3.63M	18.98M	16.83M	18.03M
Total Assets	28.82M	32.3M	28.53M	22.81M	19.73M	17.13M	22.28M	20.73M	23.71M
Account Payables	7.97M	6.57M	3.49M	2.2M	2.39M	2.28M	3.61M	10.95M	5.07M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	1.74M	3.09M	1.21M
Short-Term Debt	29.44M	35.55M	10.92M	904.2K	3.66M	11.34M	17.86M	4.67M	5.2M
Other Current Liabilities	1.01M	1.83M	3.31M	2.83M	5.06M	5.56M	4.17M	3.69M	2.16M
Total Current Liabilities	42.55M	46.73M	19.73M	6.75M	15.89M	20.29M	32.04M	28.74M	20.44M
Long-Term Debt	246.92B	n/a	n/a	10.89M	904.2K	50.28K	98.49K	13.38M	2.23M
Other Long-Term Liabilities	59.1M	6.22K	57.14K	522.92K	71.32K	4.2M	4.74M	4.84M	761.33K
Total Long-Term Liabilities	59.35M	6.22K	61.41K	11.45M	1.02M	7.61M	11.05M	22.72M	8.47M
Total Liabilities	101.9M	46.74M	19.79M	18.2M	16.91M	27.9M	43.09M	51.46M	28.91M
Total Debt	29.74M	35.56M	10.96M	11.9M	8.8M	14.95M	21.93M	18.42M	8.73M
Common Stock	239.06K	2.6M	2.27M	1.76M	1.27M	286.1K	722.2K	249.34K	228.03K
Retained Earnings	-543.28M	-467.92M	-408.94M	-342.88M	-289.72M	-254.48M	-216.31M	-186.22M	-147.39M
Comprehensive Income	n/a	n/a	417.67M	-22,811.5B	-19,732.6B	238.35M	190.76M	-8.64M	-5.96M
Shareholders Equity	-73.08M	-14.44M	8.74M	4.61M	2.83M	-10.77M	-20.81M	-30.73M	-5.2M
Total Investments	693.19K	793.93K	804.93K	853.66K	900K	n/a	n/a	n/a	216.09K